The Procter & Gamble CompanyNYSE
Advanced Chart
  • Wed, Jul. 20, 8:48 AM
    • Unilever (UL, UN) confirms it acquired Dollar Shave Club. The company didn't disclose the transaction price, but earlier reports pegged it at $1B which would make the deal the third largest buyout in the e-commerce space ever after Zulilly and Wayfair. The transaction is also an exclamation point on the disruption that Dollar Shave Club achieved in a consumer products category once considered nearly impenetrable.
    • The innovative shaving club sends razors directly to members for as little as $1 per month. Dollar Shave Club is on track to top $200M in turnover this year and has 3.2M members.
    • Earlier this week, news broke that Procter & Gamble (NYSE:PG) is increasing its testing of online subscriptions. It's a trend to watch for Colgate-Palmolive (NYSE:CL), Kimberly-Clark (NYSE:KMB), and Edgewell Personal Care (NYSE:EPC).
    • Previously: Fortune: Unilever buys Dollar Shave Club for $1B (July 20)
    | Wed, Jul. 20, 8:48 AM | 11 Comments
  • Fri, Jun. 24, 3:36 AM
    • German consumer products group Henkel (OTCPK:HENKY) is buying The Sun Products Corp from a fund of Vestar Capital Partners in a deal valued at about €3.2B ($3.5B) including debt.
    • The acquisition will add well-established laundry detergent and fabric conditioner brands to Henkel's portfolio and make it the No. 2 laundry care maker in North America behind Procter & Gamble (NYSE:PG).
    | Fri, Jun. 24, 3:36 AM | 4 Comments
  • Jul. 9, 2015, 8:40 AM
    • Coty (NYSE:COTY) is acquiring 43 of Procter & Gamble's (NYSE:PG) beauty brands in a complicated deal valued at $12.5B.
    • P&G expects to record a one-time gain of anywhere from $5B-$7B on the transaction, which includes its hair color brands, retail cosmetics and fine fragrance businesses.
    • While the final form of the deal has not yet been confirmed, P&G said it aimed to do a "Reverse Morris Trust," which involves both spinning off an asset and simultaneous merging it with something else.
    • PG +1.5%; COTY +2.2% premarket
    | Jul. 9, 2015, 8:40 AM | 45 Comments
  • Jun. 9, 2015, 3:04 AM
    • Stepping closer to shedding some more non-core assets, P&G (NYSE:PG) has received several binding offers for separate parts of its beauty business.
    • Bidders, including Henkel (OTCPK:HENKY), Coty (NYSE:COTY) and P-E firms KKR (NYSE:KKR), Clayton Dubilier & Rice and Warburg Pincus, have made offers in the billions of dollars for P&G's haircare unit, cosmetics division and fragrance business.
    • CEO Lafley said last August he would reverse the company's strategy of aggressive expansion and unload more than half of its brands.
    • Previously: Personal care companies prep bids for P&G beauty brands (Apr. 16 2015)
    | Jun. 9, 2015, 3:04 AM | 6 Comments
  • Apr. 16, 2015, 2:12 AM
    • As part of a cost-cutting strategy by Chief Executive A.G. Lafley, Procter & Gamble (NYSE:PG) may soon offload $10B-$12B worth of its beauty brands.
    • Personal care and cosmetics companies Henkel (OTCPK:HENKY), Revlon (NYSE:REV) and Coty (NYSE:COTY) are preparing bids for P&G's haircare business, cosmetics division and fragrance unit, respectively, sources told Reuters.
    • CEO Lafley said last August he would reverse the company's strategy of aggressive expansion and shed more than half of its brands.
    | Apr. 16, 2015, 2:12 AM | 3 Comments
  • Mar. 31, 2015, 6:02 PM
    • The Vicks VapoSteam U.S. liquid inhalant business had 2014 revenue of $10M. Helen of Troy (NASDAQ:HELE) has acquired it from Procter & Gamble (NYSE:PG) for an undisclosed sum. The acquisition is expected to be paid for via HELE's revolving credit facility, and to be accretive in FY16 (ends Feb. '16).
    • As part of the deal, HELE has "acquired a fully paid-up license of P&Gs Vicks VapoPad trademarks for scent pads in the United States." The company notes "the vast majority of Vicks VapoSteam and VapoPads are used in Vicks humidifiers, vaporizers and other health care devices already marketed by Helen of Troy."
    | Mar. 31, 2015, 6:02 PM | 2 Comments
  • Mar. 19, 2015, 8:19 AM
    • Inter Parfums (NASDAQ:IPAR) announces it acquired the Rochas business from Procter & Gamble (NYSE:PG) through a subsidiary.
    • The price of the acquisition was $108M.
    • The deal will include the Femme, Madame, and Eau de Rochas fashion brands.
    • The transaction is expected to close in the first half of Q1.
    • Previously: Bloomberg: Procter & Gamble weighing which beauty brands will go (Mar. 16 2015)
    | Mar. 19, 2015, 8:19 AM
  • Nov. 28, 2014, 1:29 PM
    • Reuters reports Procter & Gamble (NYSE:PG) is working with Goldman to explore a sale of its Wella hair care unit, and that a deal could fetch ~$7B.
    • P&G, which has already been busy streamlining its consumer product lineup, is said to be "exploring all options for the unit," including the sale of just a portion of it. The company bought Wella for $7B in 2003.
    • PG +1% AH.
    | Nov. 28, 2014, 1:29 PM | 3 Comments
  • Oct. 24, 2014, 7:44 AM
    • Procter & Gamble (NYSE:PG) says its will exit the battery business.
    • The form of the separation of Duracell hasn't been decided upon yet, although a split-off is preferred.
    • The transaction is expected to occur in the second half of 2015.
    • PG +1.3% premarket.
    | Oct. 24, 2014, 7:44 AM | 7 Comments
  • Sep. 21, 2014, 4:17 AM
    • Just months before its recent C-suite shuffle, Clorox (NYSE:CLX) reportedly rebuffed a takeover offer from a rival.
    • The spurned suitor valued Clorox at a 20% premium to its trading price.
    • Logical suitors include Church & Dwight (NYSE:CHD), Procter & Gamble (NYSE:PG), Jarden (NYSE:JAH) and Unilever (UL, UN)
    • In 2011 activist investor Carl Icahn offered $78/share for the company. Many believe the move was designed to tease out a strategic buyer. Shares closed Friday at $90.57.
    | Sep. 21, 2014, 4:17 AM | 12 Comments
  • Apr. 27, 2014, 1:23 AM
    • Merck (MRK) could agree a deal to sell its consumer healthcare operations this week for almost $14B, Reuters reports, with Germany's Bayer (BAYRY) and U.K.-based Reckitt Benckiser (RBGLY) the frontrunners to buy the unit.
    • Other healthcare consumer giants have also also shown interest in the business, including Procter & Gamble (PG), Novartis (NVS) and Sanofi (SNY).
    • Merck is looking to sell the operations as it only holds around 1% of the market.
    • A deal would be the latest in a wave of blockbuster transactions to have swept the healthcare sector recently, such as Pfizer's $100B+ reported offer to acquire AstroZeneca, Valeant and Bill Ackman's $47B play for Allergan, Zimmer's agreement to purchase Biomet for $13.35B, and a series of deals involving Novartis, GlaxoSmithKline and Eli Lilly.
    | Apr. 27, 2014, 1:23 AM
  • Apr. 9, 2014, 9:16 AM
    • Mars plans to buy a series of Procter & Gamble (PG) pet food brands for $2.9B.
    • P&G unloads the Iams, Eukenaba, and Natura brands as part of the deal.
    • As a result of the sale, P&G will begin reporting results for its global pet care business as a discontinued operation starting in Q2.
    • The pile of cash from the deal will go to general corporate purposes, says P&G for now.
    • PG +0.5% premarket
    | Apr. 9, 2014, 9:16 AM | 8 Comments
  • Feb. 24, 2014, 10:34 AM
    • Procter & Gamble (PG +0.3%) wants to sell a personalized healthcare unit that caters to wealthy consumers.
    • MDVIP has a network that extends to 700 physicians in 42 states with a membership price of $1.5K per year.
    • Piper Jaffray is out shopping MDVIP to interested parties. Insiders say a P-E firm will be the most likely buyer.
    | Feb. 24, 2014, 10:34 AM | 2 Comments
  • Feb. 20, 2014, 4:33 AM
    • Novartis (NVS) and Bayer (BAYRY) are among the suitors that are exploring an acquisition of Merck's (MRK) consumer-healthcare business, Reuters reports, adding that the unit could be worth $10-12B.
    • Reckitt Benckiser (RBGPF) and Procter & Gamble (PG) are also among the companies to have held talks with Merck about a deal. However, GSK (GSK) is not interested.
    • Novartis and Merck have considered swapping the latter's consumer-healthcare operations for Novartis' animal-health and human vaccines businesses, although such a deal is looking unlikely.
    | Feb. 20, 2014, 4:33 AM | 1 Comment
  • Jun. 10, 2013, 7:54 AM

    More on Coppersmith-Alere (ALR) letter: Coppersmith wants Alere to use the proceeds from any sales to slash its debt, which is almost $3.8B vs a market cap of $2.15B. The ops that Coppersmith wants Alere to sell are its health care management unit, its consumer products joint venture with P&G (PG), and possibly its toxicology unit. Coppersmith has been agitating for change since last month and has nominated three directors to Alere's board.

    | Jun. 10, 2013, 7:54 AM
  • Feb. 15, 2012, 11:58 AM

    Kellogg (K +5.2%) shares power higher after scooping up Pringles from Procter & Gamble (PG) and analysts line up to approve the deal. Deutsche Bank applauds Kellogg for expanding away from cereal, estimating snacks will now represent 46% of total sales vs. 40% previously: "This is important as almost all cultures embrace snacks while few globally embrace cereal."

    | Feb. 15, 2012, 11:58 AM